Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet
The average brokerage recommendation (ABR) for Astrazeneca (AZN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…
78,250€
0,97%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Astrazeneca (AZN) Stock Moves -0.45%: What You Should Know
In the most recent trading session, Astrazeneca (AZN) closed at $72.72, indicating a -0.45% shift from the previous trading day.…
Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead
The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities broadly…
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing
Pharmaceutical company will invest money over five years in ‘strategic partnership’ with the city’s authorities…
Astrazeneca Aktie: Marktbewegung vorausgesehen?
Der britische Pharmakonzern baut seine Präsenz im chinesischen Markt mit einem 2,5-Milliarden-Dollar Forschungszentrum in Peking aus, was Anleger vorerst skeptisch…
AstraZeneca details $2.5B investment in Chinas political center, funding R&D center, biotech pacts
AstraZeneca has shown its commitment to China amid investigations into its executives and activities,…
AstraZeneca to invest $2.5 billion in Beijing hub as it seeks to move on from China probes
British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in the…
AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals By Reuters
AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals…
British pharma giant AstraZeneca to invest $2.5 billion in new China hub
British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing,…
AstraZeneca to invest $2.5 billion in new Beijing R&D center By Investing.com
AstraZeneca to invest $2.5 billion in new Beijing R&D center…
AstraZeneca investing $2.5 bln in China as drugmaker seeks to recover from scandals
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker…
AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker…
ANGLE passes key milestone as it completes AstraZeneca assay development
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has completed two major projects for AstraZeneca PLC (LSE:AZN), expanding the use of its Parsortix liquid biopsy…
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
The latest trading day saw Astrazeneca (AZN) settling at $76.32, representing a -0.97% change from its previous close.…
Adyen and AstraZeneca gain TD Cowen’s Best Ideas recognition on growth potential By Investing.com
Adyen and AstraZeneca gain TD Cowen’s Best Ideas recognition on growth potential…